Company Legal Name
Latest Valuation
Founded Year
Headquarter
Ottobock SE & Co. KGaA is a leading German manufacturer of advanced orthopedic devices, specializing in prosthetics, orthotics, exoskeletons, and personalized mobility solutions. Founded in 1919 and headquartered in Duderstadt, Germany, the company has established itself as a global pioneer in the medical technology sector, serving patients, healthcare professionals, and rehabilitation facilities worldwide. With over a century of innovation, Ottobock has built a reputation for engineering precision and quality in mobility assistance technologies. The company continues to focus on developing cutting-edge solutions that enhance patient outcomes and independence, while expanding its digital health capabilities and personalized care services to meet evolving market demands.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





